Beane A, Salluh JIF, Haniffa R What intensive care registries can teach us about outcomes. Curr Opin Crit Care. 2021 Oct 1;27(5):537-543. doi: 10.1097/MCC.0000000000000865.
Kelly FE, Fong K, Hirsch N, Nolan JP Intensive care medicine is 60 years old: the history and future of the intensive care unit. Clin Med (Lond). 2014 Aug;14(4):376-9. doi: 10.7861/clinmedicine.14-4-376.
Lanier WL A three-decade perspective on anesthesia safety. Am Surg. 2006 Nov;72(11):985-9; discussion 1021-30, 1133-48. doi: 10.1177/000313480607201101.
Liau A, Havidich JE, Onega T, Dutton RP The National Anesthesia Clinical Outcomes Registry. Anesth Analg. 2015 Dec;121(6):1604-10. doi: 10.1213/ANE.0000000000000895.
Monaco F, Belletti A, Bove T, Landoni G, Zangrillo A Extracorporeal Membrane Oxygenation: Beyond Cardiac Surgery and Intensive Care Unit: Unconventional Uses and Future Perspectives. J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1955-1970. doi: 10.1053/j.jvca.2018.03.031. Epub 2018 Mar 20.
Shapiro FE, Jani SR, Liu X, Dutton RP, Urman RD Initial results from the National Anesthesia Clinical Outcomes Registry and overview of office-based anesthesia. Anesthesiol Clin. 2014 Jun;32(2):431-44. doi: 10.1016/j.anclin.2014.02.018.
Registry of Patients Undergoing Anesthesia or Intensive Care Maneuvers
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
